Medicina
Saila
Jagiellonian University
Cracovia, PoloniaJagiellonian University-ko ikertzaileekin lankidetzan egindako argitalpenak (88)
2024
-
Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)
Nature Reviews Cardiology
-
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
Annals of Hematology, Vol. 103, Núm. 2, pp. 451-461
2023
-
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248
-
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 6, pp. 464-481
-
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function
European heart journal, Vol. 44, Núm. 29, pp. 2659-2671
-
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
Journal of the American College of Cardiology, Vol. 82, Núm. 8, pp. 687-700
-
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37
-
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
American Journal of Cardiology, Vol. 208, pp. 16-24
-
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction
New England Journal of Medicine, Vol. 389, Núm. 10, pp. 889-898
-
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions, Vol. 16, Núm. 20, pp. 2514-2524
-
Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 7, pp. 2069-2079.e7
-
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
Leukemia
-
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107
-
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group
European heart journal, Vol. 44, Núm. 41, pp. 4340-4356
-
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1383-1392
-
Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693
-
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
Cancers, Vol. 15, Núm. 17
-
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in rome November 2022
Clinical Nutrition
-
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, Núm. 4, pp. 328-336